Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial : letter to the editor
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
September, 2023
|
| In: |
Haematologica
Year: 2023, Volume: 108, Issue: 9, Pages: 2520-2525 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2022.281636 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2022.281636 Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/haematol.2022.281636 |
| Author Notes: | Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H. Brandts, Björn Steffen, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Albrecht Reichle, Sebastian Scholl, Andreas Neubauer, Jan-Henrik Mikesch, Johannes Schetelig, Friedrich Stölzel, Michael Kramer, Annett Haake, Julia Frimmel, Alwin Krämer, Richard Schlenk, Uwe Platzbecker, Hubert Serve, Claudia D. Baldus, Carsten Müller-Tidow, Daniela Aust, Martin Bornhäuser, Gerhard Ehninger and Christian Thiede on behalf of the Study Alliance Leukemia (SAL) |
| Item Description: | Online verfügbar: 9. Februar 2023 Gesehen am 08.02.2024 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2022.281636 |